| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/13/2010 | CN100579520C Slimming appetising capsule containing natural capsicine for promoting blood circulation and reducing blood fat |
| 01/13/2010 | CN100579518C Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 01/12/2010 | US7645793 Effective ingredient and basic agent; foam suppression |
| 01/12/2010 | US7645779 Linked biaryl compounds |
| 01/12/2010 | US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
| 01/12/2010 | US7645770 Phenylalanine enamide derivatives |
| 01/12/2010 | US7645765 With water miscible solubilizer; phosphodiesterase inhibitors; cardiovascular disorders |
| 01/12/2010 | US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/12/2010 | US7645756 Nitrogenous fused heteroaromatic ring derivative |
| 01/12/2010 | US7645754 Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |
| 01/12/2010 | US7645751 Mandelic acid derivatives and their use as thrombin inhibitors |
| 01/12/2010 | US7645465 Includes acid-treatment of ginseng and bio-converting treatment, such as lactic acid bacterial fermenting and intestinal bacterial fermenting process, extracting acid treated ginseng with organic solvent to obtain organic extract, fermenting organic extract with lactic-acid bacteria Bifidobacterium KK-1 |
| 01/12/2010 | CA2483678C 6-11 bicyclic ketolide derivatives |
| 01/12/2010 | CA2438143C Modified proteins, designer toxins, and methods of making thereof |
| 01/12/2010 | CA2411418C Hydroxyformamidine derivatives and medicines containing the same |
| 01/12/2010 | CA2407838C Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/12/2010 | CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 01/12/2010 | CA2403514C 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors |
| 01/12/2010 | CA2373281C Methods of treating diabetes using a complex of igf-1 and igfbp-3 |
| 01/12/2010 | CA2346010C Derivatives of isosorbide mononitrate and its use as vasodilating agents with reduced tolerance |
| 01/12/2010 | CA2324339C Piperidine derivatives |
| 01/12/2010 | CA2306428C 3-oxo-2(h)-1,2,4 - triazine derivatives as ligands of 5ht1a receptors |
| 01/12/2010 | CA2279267C Use of 15-ketoprostaglandin e compounds as endothelin antagonist |
| 01/12/2010 | CA2276373C Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 01/12/2010 | CA2254954C Morphogen treatment for chronic renal failure |
| 01/07/2010 | WO2010003144A2 Hypotensive peptides from soy proteins and method of preparation |
| 01/07/2010 | WO2010002820A1 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 01/07/2010 | WO2010002583A2 Natriuretic polypeptides with unique pharmacologic profiles |
| 01/07/2010 | WO2010002450A2 Micelles for delivery of nitric oxide |
| 01/07/2010 | WO2010002231A2 Composition for preventing or treating hyperproliferative vascular disease containing extracts from thorns of gleditsia sinensis |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010001946A1 Triazole derivative or salt thereof |
| 01/07/2010 | WO2010001933A1 Histone modification inhibitor specific to target gene |
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | WO2010001821A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative and use of the pharmaceutical composition |
| 01/07/2010 | WO2010001365A1 Nitrogen heterocycle derivatives as proteasome modulators |
| 01/07/2010 | WO2010001185A1 Thieno [2,3-b] pyridine compounds with mglur activity |
| 01/07/2010 | WO2010000851A2 Methods for modulating angiogenesis via dystrophin dp71 |
| 01/07/2010 | WO2010000801A2 Whey protein hydrolysate containing tryptophan peptide consisting of alpha lactalbumin and the use thereof |
| 01/07/2010 | WO2010000784A1 Treatment of restenosis |
| 01/07/2010 | WO2010000673A1 N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases |
| 01/07/2010 | WO2010000545A1 A process for producing lercanidipine hc1 form v |
| 01/07/2010 | WO2010000404A1 Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract |
| 01/07/2010 | WO2010000025A1 Anti-pamp therapeutic antibodies |
| 01/07/2010 | WO2010000011A1 The use of androgens for vascular regeneration and endothelial repair |
| 01/07/2010 | WO2009140204A3 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 01/07/2010 | WO2009138195A3 Use of thiophene glycoside derivatives for producing medicaments for treatment of hypertension |
| 01/07/2010 | WO2009131687A3 Inhibitors of protein kinases |
| 01/07/2010 | WO2009120815A9 Therapeutic compositions and methods |
| 01/07/2010 | WO2009117421A3 Heterocyclic modulators of gpr119 for treatment of disease |
| 01/07/2010 | WO2009112691A3 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 01/07/2010 | WO2009071096A3 Combination of medical and physical cooling treatment of ischemic effects |
| 01/07/2010 | WO2009062143A3 Methods for the repair and/or regeneration of damaged myocardium using variants of hepatocyte growth factor |
| 01/07/2010 | US20100004448 Methods of preparing quinazolinone derivatives |
| 01/07/2010 | US20100004342 LFA-1 Inhibitors and Use Thereof |
| 01/07/2010 | US20100004333 Compositions and methods for treating cardiovascular disorders |
| 01/07/2010 | US20100004328 COMPOUND, Alpha1 ADRENERGIC RECEPTOR ANTAGONISTIC AGENT, AND COMPOSITION |
| 01/07/2010 | US20100004327 Novel Use of Ansamycin Antibiotics And Method of Screening Novel Angiogenesis Inhibitor |
| 01/07/2010 | US20100004299 Imidazo[2,1-b]thiazoles and their use as pharmaceuticals |
| 01/07/2010 | US20100004297 Novel hexafluoroisopropanol derivatives |
| 01/07/2010 | US20100004286 Novel isoindolinone derivatives having inhibitory activity against t-type calcium channel and method for preparation thereof |
| 01/07/2010 | US20100004274 Stable pharmaceutical compositions comprising a pyrimidine-sulfamide |
| 01/07/2010 | US20100004271 Heterocyclic compounds as aganist for the thyroid receptor |
| 01/07/2010 | US20100004267 Liquid preparation |
| 01/07/2010 | US20100004266 Salt or Solvate of 5-Methyl-2(Piperazin-1-Yl)Benzenesulfonic Acid |
| 01/07/2010 | US20100004264 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/07/2010 | US20100004261 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 01/07/2010 | US20100004258 Novel Heterocyclic NF-kB Inhibitors |
| 01/07/2010 | US20100004255 Method of treating arrhythmias |
| 01/07/2010 | US20100004248 Use of a Nitric Oxide Synthase Modulator for the Treatment of Cardiac Indications |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100004236 Phosphodiesterase 4 inhibitors |
| 01/07/2010 | US20100004235 Heterocyclic Substituted, Anellated Pyrazole Derivative and its uses |
| 01/07/2010 | US20100004229 Potassium Channel Inhibitors |
| 01/07/2010 | US20100004184 Anti-hypercholesterolemic compounds |
| 01/07/2010 | US20100004159 Substituted imidazolone derivatives, preparations and uses |
| 01/07/2010 | US20100003672 Cdna for human methylenetetrahydrofolate reductase and uses thereof |
| 01/07/2010 | US20100003321 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 01/07/2010 | US20100003320 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 01/07/2010 | US20100003302 Vascular restenosis preventing agent and implantable intravascular device coated therewith |
| 01/07/2010 | US20100003261 agonist anti-trk-c monoclonal antibodies |
| 01/07/2010 | US20100003244 Agents which bind to epitopes of glycoprotein vi |
| 01/07/2010 | US20100003233 Compositions and methods for treatment of microbial infections |
| 01/07/2010 | US20100003193 Unit dosage of apadenoson |
| 01/07/2010 | CA2764739A1 N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases |
| 01/07/2010 | CA2729687A1 Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract |
| 01/07/2010 | CA2729552A1 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 01/07/2010 | CA2729408A1 Triazole derivative or salt thereof |
| 01/07/2010 | CA2729405A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 01/07/2010 | CA2728769A1 Nitrogen heterocycle derivatives as proteasome modulators |
| 01/06/2010 | EP2141160A1 Ground crystal of olmesartan medoxomil |
| 01/06/2010 | EP2141154A1 Oxazolidinone derivative having inhibitory activity on 11 -hydroxysteroid dehydrogenase type i |
| 01/06/2010 | EP2141150A1 Bicyclic compound and pharmaceutical use thereof |
| 01/06/2010 | EP2141148A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same |
| 01/06/2010 | EP2140881A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 01/06/2010 | EP2140867A1 Pharmaceutical composition |
| 01/06/2010 | EP2140866A1 Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract |
| 01/06/2010 | EP2139994A2 2786, a human aminopeptidase |
| 01/06/2010 | EP2139877A1 Deuterated piperazine derivatives as anti-anginal compounds |
| 01/06/2010 | EP2139866A2 Crystalline 1-(cyclohexyloxycarbonyloxy) ethyl 1-((2'-cyanobiphenyl-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate and a process for its preparation |